BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1501109)

  • 1. The binding properties of the solubilized sulfonylurea receptor from a pancreatic B-cell line are modulated by the Mg(++)-complex of ATP.
    Schwanstecher M; Behrends S; Brandt C; Panten U
    J Pharmacol Exp Ther; 1992 Aug; 262(2):495-502. PubMed ID: 1501109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate and thiophosphate group donating adenine and guanine nucleotides inhibit glibenclamide binding to membranes from pancreatic islets.
    Schwanstecher M; Löser S; Rietze I; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):83-9. PubMed ID: 1903188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding properties of the particulate and solubilized sulfonylurea receptor from cerebral cortex are modulated by the Mg2+ complex of ATP.
    Schwanstecher M; Schaupp U; Löser S; Panten U
    J Neurochem; 1992 Oct; 59(4):1325-35. PubMed ID: 1402884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
    Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
    Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of protein phosphorylation in the regulation of the sulphonylurea receptor of a pancreatic beta-cell line, HIT T15.
    Niki I; Ashcroft SJ
    Biochim Biophys Acta; 1991 Dec; 1133(1):95-101. PubMed ID: 1836360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-cell glibenclamide receptor is an ADP-binding protein.
    Niki I; Nicks JL; Ashcroft SJ
    Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and solubilization of the sulphonylurea receptor in rat brain.
    Niki I; Ashcroft SJ
    Neuropharmacology; 1993 Oct; 32(10):951-7. PubMed ID: 8295717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the sulfonylurea receptor on beta cell membranes.
    Gaines KL; Hamilton S; Boyd AE
    J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of beta-cells.
    Schwanstecher C; Meyer M; Schwanstecher M; Panten U
    Br J Pharmacol; 1998 Mar; 123(6):1023-30. PubMed ID: 9559882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea receptors and ATP-sensitive K+ channels in clonal pancreatic alpha cells. Evidence for two high affinity sulfonylurea receptors.
    Rajan AS; Aguilar-Bryan L; Nelson DA; Nichols CG; Wechsler SW; Lechago J; Bryan J
    J Biol Chem; 1993 Jul; 268(20):15221-8. PubMed ID: 8325894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets.
    Schwanstecher M; Löser S; Brandt C; Scheffer K; Rosenberger F; Panten U
    Br J Pharmacol; 1992 Mar; 105(3):531-4. PubMed ID: 1628141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the solubilized glibenclamide receptor in a hamster pancreatic beta-cell line, HIT T15.
    Niki I; Welsh M; Berggren PO; Hubbard P; Ashcroft SJ
    Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):619-24. PubMed ID: 1908219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
    Hambrock A; Löffler-Walz C; Quast U
    Br J Pharmacol; 2002 Aug; 136(7):995-1004. PubMed ID: 12145099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of protein phosphorylation on the sulphonylurea receptor of the pancreatic beta-cell.
    Niki I; Coles B; Ashcroft FM; Ashcroft SJ
    Adv Exp Med Biol; 1997; 426():59-69. PubMed ID: 9544256
    [No Abstract]   [Full Text] [Related]  

  • 15. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
    Löffler-Walz C; Hambrock A; Quast U
    Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog.
    Aguilar-Bryan L; Nelson DA; Vu QA; Humphrey MB; Boyd AE
    J Biol Chem; 1990 May; 265(14):8218-24. PubMed ID: 2110566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP/ADP binding sites are present in the sulfonylurea binding protein associated with brain ATP-sensitive K+ channels.
    Bernardi H; Fosset M; Lazdunski M
    Biochemistry; 1992 Jul; 31(27):6328-32. PubMed ID: 1627571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
    Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
    Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.